Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 27, 2025 | Vitalgen Completes Phase III Enrollment for VGR-R01 Gene Therapy Targeting Bietti Crystalline Dystrophy | Company on track for BLA submission in H2 2026 for potential first-in-class treatment Completing enrollment for our Phase III trial represents a pivotal milestone in bringing the first potential treatment to BCD patients who currently have ... |
| May 12, 2025 | Grit Biotechnology Presents Multiple Scientific Breakthroughs at ASGCT 2025 Annual Meeting | SHANGHAI, May 12, 2025 /PRNewswire/ -- Grit Biotechnology Co., Ltd. ("Grit Bio"), a clinical-stage biotech pioneering novel immunotherapies announced today that three research programs, in collaboration with Vitalgen BioPharma Co.... |
| Apr 15, 2025 | Vitalgen to Present Advanced Gene Therapy Pipeline and Parkinson's Disease Progress at BIO International Convention 2025 | Vitalgen, a pioneer in transformative gene therapies with vertically integrated proprietary platforms, will participate in the upcoming BIO 2025 Convention We're excited to present Vitalgen's latest breakthroughs in gene therapy at BIO 2025... |
| Apr 15, 2025 | Vitalgen's Cutting-Edge Gene Editing and Delivery Platforms to be Featured at AACR Annual Meeting 2025 | Collaborative research with Grit Biotechnology showcases Vitalgen's proprietary platform and delivery systems in oncology applications These AACR presentations showcase how our proprietary platforms can enable breakthrough therapies across ... |
Reviews 0
FAQ about Vitalgen
What has the press written about Vitalgen?
Parsers VC has collected 5 articles mentioning Vitalgen, among them “Vitalgen Completes Phase III Enrollment for VGR-R01 Gene Therapy Targeting Bietti Crystalline Dystrophy” (May 27, 2025) and “Grit Biotechnology Presents Multiple Scientific Breakthroughs at ASGCT 2025 Annual Meeting” (May 12, 2025).
Is Vitalgen still active?
Yes, Vitalgen is active; its latest activity on Parsers VC dates from Jun 30, 2025.